Fewer cases of melanoma, lower investigator-estimated risk class of skin cancer observed in atopic versus nonatopic individuals

39.1 percent of baricitinib 4-mg-treated patients with SALT score >20 at week 52 achieved SALT score ≤20 by week 104

Improvement seen in primary and key secondary end points, including peak pruritus numerical rating scale, sleep disturbance

Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50

Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104

Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis

Significant differences seen for insurance status, income, education, Charlson-Deyo score, stage for Hispanic, White patients

Disease severity decreased by about 50 percent in the lovastatin-cholesterol and lovastatin-alone treatment groups

However, based on genetic analysis, smoking may not be a causal factor of psoriasis

No difference seen in keratinocyte cancers or actinic keratoses for organ-transplant recipients receiving oral nicotinamide or placebo

Medical costs, LOS higher with plasmapheresis first versus intravenous immunoglobulin first for Stevens-Johnson syndrome and toxic epidermal necrolysis

Patient use of machine learning algorithm led to reduction in number of patients with poor-quality images

About 31 percent of patients with recalcitrant alopecia areata totalis or universalis had complete hair regrowth

Event-free survival longer for those receiving neoadjuvant and adjuvant pembrolizumab versus adjuvant pembrolizumab only

Significantly greater proportion of patients achieved Clinical Erythema Assessment success with paroxetine versus placebo

Combination of 5FU after microneedling and excimer more suitable for localized, focal vitiligo

Concerns were few and included not understanding notes or abbreviations

Standardized prevalence highest in those aged 30 to 39, 40 to 49 years; Asians, Blacks, Hispanic/Latinos have increased prevalence ratios

Prevalence and incidence higher for females versus males, adults versus children and teens, in Northeast versus other regions

Only race/ethnicity with increase was non-Hispanic Whites; increases seen for those aged 31 to 40, 51 to 64 years

People with psoriasis have double the odds of celiac disease versus people without psoriasis

Black children with asthma less likely to have seen an allergist, more likely to lack prior inhalant allergy testing

When restricting analysis to patients with psoriasis, methotrexate was only associated with basal cell carcinoma